Arabi Yaseen M, Dara Saqib I, Tamim Hani M, Rishu Asgar H, Bouchama Abderrezak, Khedr Mohammad K, Feinstein Daniel, Parrillo Joseph E, Wood Kenneth E, Keenan Sean P, Zanotti Sergio, Martinka Greg, Kumar Aseem, Kumar Anand
Crit Care. 2013 Apr 17;17(2):R72. doi: 10.1186/cc12680.
Data are sparse as to whether obesity influences the risk of death in critically ill patients with septic shock. We sought to examine the possible impact of obesity, as assessed by body mass index (BMI), on hospital mortality in septic shock patients.
We performed a nested cohort study within a retrospective database of patients with septic shock conducted in 28 medical centers in Canada, United States and Saudi Arabia between 1996 and 2008. Patients were classified according to the World Health Organization criteria for BMI. Multivariate logistic regression analysis was performed to evaluate the association between obesity and hospital mortality.
Of the 8,670 patients with septic shock, 2,882 (33.2%) had height and weight data recorded at ICU admission and constituted the study group. Obese patients were more likely to have skin and soft tissue infections and less likely to have pneumonia with predominantly Gram-positive microorganisms. Crystalloid and colloid resuscitation fluids in the first six hours were given at significantly lower volumes per kg in the obese and very obese patients compared to underweight and normal weight patients (for crystalloids: 55.0 ± 40.1 ml/kg for underweight, 43.2 ± 33.4 for normal BMI, 37.1 ± 30.8 for obese and 27.7 ± 22.0 for very obese). Antimicrobial doses per kg were also different among BMI groups. Crude analysis showed that obese and very obese patients had lower hospital mortality compared to normal weight patients (odds ratio (OR) 0.80, 95% confidence interval (CI) 0.66 to 0.97 for obese and OR 0.61, 95% CI 0.44 to 0.85 for very obese patients). After adjusting for baseline characteristics and sepsis interventions, the association became non-significant (OR 0.80, 95% CI 0.62 to 1.02 for obese and OR 0.69, 95% CI 0.45 to 1.04 for very obese).
The obesity paradox (lower mortality in the obese) documented in other populations is also observed in septic shock. This may be related in part to differences in patient characteristics. However, the true paradox may lie in the variations in the sepsis interventions, such as the administration of resuscitation fluids and antimicrobial therapy. Considering the obesity epidemic and its impact on critical care, further studies are warranted to examine whether a weight-based approach to common therapeutic interventions in septic shock influences outcome.
关于肥胖是否会影响感染性休克重症患者的死亡风险,相关数据较为匮乏。我们试图探讨以体重指数(BMI)评估的肥胖对感染性休克患者医院死亡率的可能影响。
我们在1996年至2008年期间于加拿大、美国和沙特阿拉伯的28个医疗中心开展的感染性休克患者回顾性数据库中进行了一项巢式队列研究。患者根据世界卫生组织的BMI标准进行分类。采用多因素逻辑回归分析来评估肥胖与医院死亡率之间的关联。
在8670例感染性休克患者中,2882例(33.2%)在重症监护病房(ICU)入院时记录了身高和体重数据,构成研究组。肥胖患者更易发生皮肤和软组织感染,而肺炎伴主要革兰氏阳性微生物感染的可能性较小。与体重过轻和正常体重患者相比,肥胖和极度肥胖患者在前六个小时给予的晶体液和胶体复苏液每千克体积显著更低(晶体液:体重过轻患者为55.0±40.1毫升/千克,正常BMI患者为43.2±33.4,肥胖患者为37.1±30.8,极度肥胖患者为27.7±22.0)。每千克抗菌药物剂量在不同BMI组之间也存在差异。粗分析显示,与正常体重患者相比,肥胖和极度肥胖患者的医院死亡率更低(肥胖患者的比值比(OR)为0.80,95%置信区间(CI)为0.66至0.97;极度肥胖患者的OR为0.61,95%CI为0.44至0.85)。在对基线特征和脓毒症干预措施进行调整后,这种关联变得不显著(肥胖患者的OR为0.80,95%CI为0.62至1.02;极度肥胖患者的OR为0.69,95%CI为0.45至1.04)。
在感染性休克患者中也观察到了其他人群中记录的肥胖悖论(肥胖者死亡率更低)。这可能部分与患者特征差异有关。然而,真正的悖论可能在于脓毒症干预措施的差异,如复苏液的输注和抗菌治疗。鉴于肥胖流行及其对重症监护的影响,有必要进一步开展研究,以探讨针对感染性休克常见治疗干预措施采用基于体重的方法是否会影响预后。